SCHEMBL6473137

SCHEMBL6473137

O=C(O)CCc1ccc(Oc2cc(I)c(O)c(I)c2)c(I)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
NR1I2 O75469 1/20 0.63
AGTR2 P50052 1/20 0.63
BLM P54132 1/20 0.63
FFAR1 O14842 4/20 0.58
THRB P10828 4/20 0.53
THRA P10827 3/20 0.53
PCNA P12004 2/20 0.53
POLB P06746 1/20 0.53
MAPK1 P28482 1/20 0.53
HIF1A Q16665 1/20 0.53
ITGB3 P05106 1/20 0.52
ITGAV P06756 1/20 0.52
RXRA P19793 1/20 0.52
TAAR5 O14804 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
FFAR4 Q5NUL3 3/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6474460 0.86 PPARG (0.67) PPARGMEN1KMT2ANR1I2AGTR2
SCHEMBL17874460 0.84 FFAR1 (0.64) PPARGMEN1KMT2ANR1I2AGTR2
SCHEMBL13886593 0.81 TAAR1 (0.74) PPARGMEN1KMT2ANR1I2AGTR2
SCHEMBL4238467 0.81 THRB (0.73) PPARGMEN1KMT2ANR1I2AGTR2
SCHEMBL27294205 0.81 PPARG (0.60) PPARGMEN1KMT2ANR1I2AGTR2
SCHEMBL1446398 0.81 FFAR1 (0.65) FFAR1PCNAFFAR4
SCHEMBL6473141 0.81 FFAR1 (0.58) PPARGMEN1KMT2ANR1I2AGTR2
SCHEMBL1270234 0.78 PCNA (0.57) PPARGFFAR1THRBTHRAPCNA
SCHEMBL14230054 0.78 PPARG (0.53) PPARGMEN1KMT2ANR1I2AGTR2
Reversetriiodothyronine SCHEMBL93386 0.77 MEN1 (1.00) PPARGMEN1KMT2ANR1I2AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005123099-A2 METHODS AND COMPOSITIONS FOR ACCELERATING ALCOHOL METABOLISM ENZYMEDIX, INC. (US) 2005-12-29 WO claimed
US-20050271739-A1 Methods and compositions for accelerating alcohol metabolism ENZYMEDIX 2005-12-08 US claimed
WO-2005123099-A2 METHODS AND COMPOSITIONS FOR ACCELERATING ALCOHOL METABOLISM ENZYMEDIX, INC. (US) 2005-12-29 WO disclosed
US-20050271739-A1 Methods and compositions for accelerating alcohol metabolism ENZYMEDIX 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050271739-A1 Methods and compositions for accelerating alcohol metabolism ADH1A, ADH1C, ADH5 PPARG 847/4885MEN1 3764/4885KMT2A 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.